Enterprise Products Partners L.P. (NYSE:EPD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fourteen analysts that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy […]
StockNews.com upgraded shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) from a buy rating to a strong-buy rating in a research note released on Thursday morning. A number of other brokerages also recently issued reports on BMY. BMO Capital Markets cut their price objective on Bristol-Myers Squibb from $55.00 to $48.00 and set a market […]
Greylin Investment Management Inc lessened its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 15.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,115 shares of the biopharmaceutical company’s stock after selling 750 shares during the period. Greylin Investment Management Inc’s holdings in […]
Bristol-Myers Squibb (NYSE:BMY – Get Free Report)’s share price fell 1.4% on Tuesday . The company traded as low as $42.71 and last traded at $42.75. 3,665,630 shares changed hands during trading, a decline of 76% from the average session volume of 15,375,505 shares. The stock had previously closed at $43.36. Analyst Ratings Changes A […]
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) shares were down 1.4% during trading on Tuesday . The stock traded as low as $42.71 and last traded at $42.75. Approximately 3,665,630 shares traded hands during trading, a decline of 76% from the average daily volume of 15,375,505 shares. The stock had previously closed at $43.36. Analyst […]